ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 845 filers reported holding ISHARES TR in Q1 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $982,659 | -55.5% | 8,014 | -53.9% | 0.17% | -43.8% |
Q2 2023 | $2,209,231 | -1.7% | 17,401 | 0.0% | 0.30% | -16.0% |
Q1 2023 | $2,247,513 | -2.1% | 17,401 | -0.4% | 0.36% | -10.2% |
Q4 2022 | $2,294,818 | +12.6% | 17,479 | +0.3% | 0.40% | +2.5% |
Q3 2022 | $2,038,000 | -1.8% | 17,422 | -1.3% | 0.39% | -1.0% |
Q2 2022 | $2,076,000 | -24.3% | 17,648 | -16.2% | 0.40% | -12.7% |
Q1 2022 | $2,743,000 | -14.8% | 21,049 | -0.2% | 0.46% | -20.7% |
Q4 2021 | $3,218,000 | -5.9% | 21,085 | -0.3% | 0.57% | -15.0% |
Q3 2021 | $3,421,000 | -1.2% | 21,158 | 0.0% | 0.68% | +35.3% |
Q2 2021 | $3,462,000 | +16.4% | 21,158 | +7.2% | 0.50% | +8.0% |
Q1 2021 | $2,973,000 | -18.1% | 19,745 | -17.6% | 0.46% | -26.9% |
Q4 2020 | $3,630,000 | +11.9% | 23,962 | 0.0% | 0.63% | -5.7% |
Q3 2020 | $3,244,000 | -3.9% | 23,962 | -3.0% | 0.67% | -37.3% |
Q2 2020 | $3,376,000 | +47.6% | 24,704 | +16.3% | 1.07% | +12.2% |
Q1 2020 | $2,288,000 | -1.7% | 21,239 | +9.9% | 0.95% | +29.0% |
Q4 2019 | $2,328,000 | – | 19,320 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |